Pharmacies - Saudi Arabia | Statista Market Forecast

The Pharmacies market in Saudi Arabia is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is set to reach US$7.38bn in 2024.
Furthermore, it is anticipated that the market will experience a compound annual growth rate (CAGR) of 5.43% between 2024 and 2029, resulting in a market volume of US$9.61bn by 2029.
When compared to other countries globally, United States is expected to generate the highest revenue in the Pharmacies market, reaching a staggering US$387.30bn in 2024.
This highlights the dominance of the US in the global pharmaceutical industry.
In terms of per capita revenue, in 2024, each person in Saudi Arabia is projected to generate approximately US$196.90.
This indicates the significant contribution of the Pharmacies market to the overall economy of the country.
With the increasing demand for healthcare services, Saudi Arabia is witnessing a surge in the establishment of modern and advanced pharmacies.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in Saudi Arabia has been experiencing significant growth in recent years.

Customer preferences: Customers in Saudi Arabia have shown a strong preference for pharmacies that offer a wide range of products and services. They value convenience and accessibility, and are increasingly seeking out pharmacies that provide a one-stop solution for their healthcare needs. This includes not only prescription medications, but also over-the-counter drugs, health and wellness products, and personal care items. In addition, customers in Saudi Arabia are becoming more health-conscious and are actively seeking out pharmacies that offer specialized services such as nutrition counseling and disease management programs.

Trends in the market: One of the key trends in the Pharmacies market in Saudi Arabia is the increasing adoption of technology. Pharmacies are leveraging digital platforms to enhance customer experience and streamline operations. This includes online ordering and delivery services, as well as the use of mobile apps for medication reminders and health tracking. Furthermore, pharmacies are investing in electronic health record systems to improve patient safety and facilitate better communication with healthcare providers. Another trend in the market is the growing demand for generic medications. With rising healthcare costs, customers in Saudi Arabia are looking for more affordable alternatives to brand-name drugs. Pharmacies are responding to this demand by expanding their range of generic medications and offering competitive pricing. This trend is expected to continue as the government in Saudi Arabia continues to promote the use of generic drugs to reduce healthcare expenditure.

Local special circumstances: Saudi Arabia has a rapidly growing population, with a large proportion of young people. This demographic trend is driving the demand for healthcare services, including pharmacies. In addition, the government in Saudi Arabia has been investing heavily in the healthcare sector, with a focus on improving access to quality healthcare services. This includes the expansion of healthcare infrastructure and the implementation of healthcare reforms. As a result, there is a growing need for pharmacies to cater to the increasing demand for healthcare products and services.

Underlying macroeconomic factors: The Pharmacies market in Saudi Arabia is also influenced by macroeconomic factors. The country has a strong economy and a high per capita income, which enables customers to afford healthcare products and services. Furthermore, the government in Saudi Arabia has implemented policies to promote local manufacturing of pharmaceutical products, which has led to the growth of the domestic pharmaceutical industry. This has created opportunities for pharmacies to source locally-produced medications and reduce dependence on imports. In conclusion, the Pharmacies market in Saudi Arabia is experiencing growth due to customer preferences for convenience and a wide range of products and services. The market is also being driven by trends such as the adoption of technology and the demand for generic medications. Local special circumstances, such as a growing population and government investments in healthcare, are further contributing to the growth of the market. Additionally, underlying macroeconomic factors such as a strong economy and government policies are creating a favorable environment for pharmacies in Saudi Arabia.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.